Shan-Lu Liu, Ph.D.

University of Washington, Seattle, Seattle, WA 
"Shan-Lu Liu"
Mean distance: 17.35 (cluster 6)


Sign in to add mentor
A. Dusty Miller grad student 2003 University of Washington
 (Sheep retroviral envelope glycoproteins: Mechanisms of oncogenesis and incorporation into HIV-1 lentiviral vectors.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hersi F, Sebastian A, Tarazi H, et al. (2023) Discovery of novel papain-like protease inhibitors for potential treatment of COVID-19. European Journal of Medicinal Chemistry. 254: 115380
Shamseldin MM, Kenney A, Zani A, et al. (2023) Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology. Journal of Immunology (Baltimore, Md. : 1950)
Azar JH, Evans JP, Sikorski MH, et al. (2023) Selective suppression of de novo SARS-CoV2 vaccine antibody responses in cancer patients on B cell-targeted therapy. Jci Insight
Qu P, Evans JP, Kurhade C, et al. (2023) Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants. Mbio. e0317622
Qu P, Evans JP, Kurhade C, et al. (2022) Determinants and Mechanisms of the Low Fusogenicity and Endosomal Entry of Omicron Subvariants. Biorxiv : the Preprint Server For Biology
Cui Z, Zeng C, Huang F, et al. (2022) Cas13d knockdown of lung protease Ctsl prevents and treats SARS-CoV-2 infection. Nature Chemical Biology
Tang J, Zeng C, Cox TM, et al. (2022) Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination. Science Immunology. eadd4853
Evans JP, Qu P, Zeng C, et al. (2022) Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants. The New England Journal of Medicine
Evans JP, Zeng C, Qu P, et al. (2022) Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2. Cell Host & Microbe
Gyang TV, Evans JP, Miller JS, et al. (2022) Neutralizing antibody responses against SARS-CoV-2 in vaccinated people with multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 8: 20552173221087357
See more...